×
About 5 results

ALLMedicine™ Aortitis Center - News

Polymyalgia rheumatica: Clinical presentation is key to diagnosis and treatment
https://www.mdedge.com/ccjm/article/94208/rheumatology/polymyalgia-rheumatica-clinical-presentation-key-diagnosis-and
Brian F. Mandell, MD, PhD

ABSTRACTPolymyalgia rheumatica should be considered in the differential diagnosis in patients over 50 years old who present with bilateral achiness and stiffness in the shoulders or hips or both. It usually responds quickly to once-daily, low-dose prednisone, but some patients require treatment for several years.

In reply: Giant cell arteritis
https://www.mdedge.com/ccjm/article/95500/vascular/reply-giant-cell-arteritis?channel=164
Alexandra Villa-Forte, MD, MPH

Aug 1st, 2011 - In Reply: We know from autopsy studies that most patients with giant cell arteritis, if not all, develop aortitis at some point during the course of their disease, but we don’t know (and no study yet has completely addressed) the following questions: What is the most clinically appropriate and cost-effective method of screening? How often should we be screening these patients? Given the high co.

Remain Connected on Connect
https://www.mdedge.com/vascularspecialistonline/article/202603/society-news/remain-connected-connect?channel=28399

Jun 17th, 2019 - How have you managed a possible infected aortitis, a severe focal stenosis or a fractured carotid stent? Give your input in discussions about these topics, and more, on your online community, SVSConnect. If you attended VAM last week, continue the discussions with other attendees.

IgG4-Related Systemic Aortitis Responds to Rituximab
https://www.mdedge.com/rheumatology/article/45629/lupus-connective-tissue-diseases/igg4-related-systemic-aortitis-responds
Sharon Worcester

Jul 1st, 2011 - CHICAGO – Rituximab is showing promise as an effective treatment for IgG4-related aortitis, a condition which has only recently been described. In one patient with aortitis and a high serum IgG4 level of 1,560 mg/dL, treatment with rituximab resulted in a decrease to 390 mg/dL within 2 months.

New Treatment Strategies in Large-vessel Vasculitis
https://www.medscape.com/viewarticle/776095_8

Rituximab and Tocilizumab With Other Large-vessel Vasculitides IgG4-related disease (IgG4-RD) is a disorder characterized by elevated serum IgG4 levels and the infiltration of tissue by increased numbers of IgG4-expressing plasma cells along with fibrosis. Although almost any organ may be involved, IgG4-RD involvement of the aorta results in a lymphoplasmacytic aortitis or periaortitis.[54] Kho...